The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Roche/Genentech
Stock and Other Ownership Interests - Exelixis; Roche/Genentech
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Safety and clinical activity results from a phase Ib study of alectinib plus atezolizumab in ALK+ advanced NSCLC (aNSCLC).
 
Dong-Wan Kim
No Relationships to Disclose
 
Shirish M. Gadgeel
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Pfizer
Speakers' Bureau - AstraZeneca
Research Funding - ACEA Biosciences (Inst); Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck; Merck (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - ARIAD/Takeda; Genentech/Roche
 
Scott N. Gettinger
Consulting or Advisory Role - Alexion Pharmaceuticals; Bristol-Myers Squibb; Pfizer
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck
 
Gregory J. Riely
Consulting or Advisory Role - Genentech
Research Funding - ARIAD (Inst); GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent application submitted covering pulsatile use of erlotinib to treat or prevent brain metastases (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Geoffrey R. Oxnard
Honoraria - Bio-Rad; Chugai Pharma; Guardant Health; Sysmex
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; DropWorks; Genentech/Roche; GRAIL; Ignyta; Inivata; LOXO; Novartis; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)
 
Tarek Mekhail
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck
 
Peter Schmid
Employment - Roche (I)
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche (I); Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Medivation (Inst); Merck (Inst); Novartis (Inst); Oncogenex (Inst); Roche (Inst)
 
Afshin Dowlati
Consulting or Advisory Role - ARIAD
Research Funding - Abbvie; BMS Brazil; EMD Serono; EMD Serono; Loxo; Mirati Therapeutics; Tesaro
 
Rebecca Suk Heist
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Abbvie (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Debiopharm Group (Inst); Exelixis (Inst); Incyte (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Peregrine Pharmaceuticals (Inst); Roche (Inst)
 
Antoinette J. Wozniak
Consulting or Advisory Role - ARIAD; Array BioPharma; AstraZeneca; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Coherus Biosciences; Epic; Hospira; Huron Consulting; HUYA Bioscience International; Quintiles; Takeda; WCCT Global
Research Funding - Boehringer Ingelheim
 
Genevive Hernandez
Employment - Genentech; Genentech (I)
Stock and Other Ownership Interests - Roche/Genentech (I)
 
Indrani Sarkar
Employment - Genentech
 
Emmanuel Mitry
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Paul Foster
No Relationships to Disclose
 
Carol O'Hear
No Relationships to Disclose
 
Jessica Spahn
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - TP Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Foundation Medicine; Genentech/Roche; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Foundation Medicine; Ignyta; Novartis; Pfizer; Roche/Genentech; Takeda; TP Therapeutics
Speakers' Bureau - AstraZeneca; Genentech; Takeda
Research Funding - ARIAD (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Chugai Pharma (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Roche Pharma AG (Inst)